Greg Steinbock
Urology · Jeffersonville, INNPI 1972590057
Payments from drug & device makers
What this record shows
The money is spread across several categories — ownership interests (53.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Whip Mix Corporation at 53.4% of the total. Reporting peaked in 2022 at $60,986 and has fallen 90.4% since, to $5,843 in 2023. Among urology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 635 payments — averaging $211.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Whip Mix Corporation$72K
- Bayer$18K
- Merck$10K
- Astellas Pharma US Inc$10K
- Pfizer$8K
- Johnson & Johnson$7K
- plus $10K from 28 others
Across 3 payments — averaging $14,441 each. An ownership or investment interest held by the physician or an immediate family member.
- Whip Mix Corporation$43K
What the payments were for
- Consulting fees$20,14415%
- Speaking & faculty fees$20,40615%
- Travel & lodging$8,2036%
- Food & beverage$13,37410%
- Education$3390%
- Ownership interest$71,66253%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Whip Mix Corporation | 7 | $71,662 |
| Bayer | 92 | $17,535 |
| Merck | 33 | $10,279 |
| Astellas Pharma US Inc | 67 | $9,615 |
| Pfizer | 47 | $7,984 |
| Johnson & Johnson | 117 | $6,816 |
| Clovis Oncology, Inc. | 7 | $2,332 |
| Exelixis Inc. | 1 | $1,980 |
| Dendreon Pharmaceuticals LLC | 116 | $1,728 |
| Medtronic(2 entities) | 13 | $1,039 |
| Blue Earth Diagnostics | 22 | $620 |
| Amgen | 25 | $493 |
| AbbVie | 25 | $467 |
| AstraZeneca | 10 | $178 |
| Novartis | 9 | $161 |
| Boston Scientific | 2 | $152 |
| Teleflex LLC | 2 | $133 |
| Urogen Pharma, Inc. | 1 | $120 |
| Siemens Medical Solutions USA, Inc. | 1 | $117 |
| Myovant Sciences Inc. | 5 | $99 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| Foundation Medicine, Inc. | 6 | $83 |
| Sun Pharmaceutical Industries Inc. | 4 | $72 |
| Endo Pharmaceuticals Inc. | 3 | $72 |
| Axonics, Inc. | 3 | $49 |
| Tolmar Pharmaceuticals, Inc. | 2 | $46 |
| Ferring Pharmaceuticals Inc. | 2 | $45 |
| Progenics Pharmaceuticals, Inc. | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Neotract Inc. | 1 | $25 |
| Coloplast | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Accord Healthcare, Inc. | 1 | $17 |
| Angiodynamics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XTANDI$14,171
- Nubeqa$12,367
- LYNPARZA$9,638
- VeriSplint$7,626
- Erleada$5,076
- Xofigo$3,620
- Rubraca$2,149
- Cabometyx$1,980
- INTERSTIM$619
- PROVENGE$247
- KEYTRUDA$124
- Axumin$122
- GENERAL - THERAPIES$121
- JELMYTO$120
- Varian CRYOCARE TOUCH System$117
- UroLift System$112
- Lupron Depot$110
- XGEVA$106
How this compares
$134,128 in reported general payments places this provider in the 95th percentile of 272 urology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NubeqaDarolutamide | 11 | $137,970 |
| Tamsulosin Hcl | 19 | $221 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| BayerNubeqa | $17,535 | $137,97011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 272 urology providers in Indiana.
Other urology in Jeffersonville
- James BailenJeffersonville$143K
- Ryan MaloneJeffersonville$97K
- William SchmiedJeffersonville$58K
- Barry PechaJeffersonville$50K
- David RosenbaumJeffersonville$39K
- John EiflerJeffersonville$26K
- Ganesh RaoJeffersonville$19K
- Bradley BellJeffersonville$16K
- Aaron BeckerJeffersonville$14K
- Dennis SmithJeffersonville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.